Clinical Trials
5
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase III Trial of VDJ001 In Patients With Moderate-to-severe Active Rheumatoid Arthritis
- Conditions
- Rheumatoid Arthritis (RA)
- Interventions
- First Posted Date
- 2024-12-10
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- Beijing VDJBio Co., LTD.
- Target Recruit Count
- 615
- Registration Number
- NCT06726096
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
Phase II Trial of VDJ001 in Patients With Moderate-to-severe Active Rheumatoid Arthritis
- Conditions
- Rheumatoid Arthritis
- Interventions
- First Posted Date
- 2023-07-24
- Last Posted Date
- 2025-07-09
- Lead Sponsor
- Beijing VDJBio Co., LTD.
- Target Recruit Count
- 181
- Registration Number
- NCT05957107
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
🇨🇳Baoji Central Hospital, Baoji, China
🇨🇳Beijing Hospital, Beijing, China
A Study of Anti-IL-6R mAb Injection in Patients With iMCD
- Conditions
- Idiopathic Multicentric Castleman's Disease
- First Posted Date
- 2022-04-26
- Last Posted Date
- 2023-07-24
- Lead Sponsor
- Beijing VDJBio Co., LTD.
- Target Recruit Count
- 9
- Registration Number
- NCT05345522
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
🇨🇳Peking University First Hospital, Beijing, China
🇨🇳West China Hospital of Sichuan Hospital, Chengdu, China
Clinical Study of Recombinant Humanized CTLA-4-FC Fusion Protein Injection in Healthy Subjects
- Conditions
- Health Volunteer
- First Posted Date
- 2022-02-25
- Last Posted Date
- 2024-05-07
- Lead Sponsor
- Beijing VDJBio Co., LTD.
- Target Recruit Count
- 46
- Registration Number
- NCT05256719
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, China
Clinical Study of Single Dose IL-6R mAb Injection in RA Patients
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2022-02-09
- Last Posted Date
- 2022-03-11
- Lead Sponsor
- Beijing VDJBio Co., LTD.
- Target Recruit Count
- 40
- Registration Number
- NCT05232396
- Locations
- 🇨🇳
Affiliated Hospital of Hebei University, Baoding, China
🇨🇳Peking University People's Hospital, Beijing, China
🇨🇳The First Affiliated Hospital of Bengbu Medical College, Bengbu, China